Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

A new tool for antimicrobial suceptibility testing

A new susceptibility testing system should help standardise and streamline the development of new antimicrobial agents.

Dr Jackie Rodgers, Oxoid Ltd (June 2000)

Keywords: clinical development, clinical trials, pharmaceutical development, pharmacodynamics, pharmacoeconomics, pharmaco-conomics, toxicology, pharmacokinetics, phase I, phase ii, canda, phase iii, phase iv, edm systems, electronic submission, clintrial, clinical trial approvals, drug launches, approvals, pharmacogenomics, Clinical Trials Section-articles clinical research, clinical trial supplies, post-marketing surveillance, regulatory and approval services, regulatory data, drug patent, drug registration, Oxoid Ltd, antimicrobial susceptibility testing, antimicrobial agents

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |